Fioretti, F., Butler, J., Udell, J. A., Schuyler Jones, W., Petrie, M. C., Harrington, J., . . . Anker, S. D. (2025). Empagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MI. ESC heart failure. https://doi.org/10.1002/ehf2.15393
Chicago Style (17th ed.) CitationFioretti, Francesco, et al. "Empagliflozin After Myocardial Infarction with or Without Diabetes and Chronic Kidney Disease: Insights from EMPACT-MI." ESC Heart Failure 2025. https://doi.org/10.1002/ehf2.15393.
MLA (9th ed.) CitationFioretti, Francesco, et al. "Empagliflozin After Myocardial Infarction with or Without Diabetes and Chronic Kidney Disease: Insights from EMPACT-MI." ESC Heart Failure, 2025, https://doi.org/10.1002/ehf2.15393.
Warning: These citations may not always be 100% accurate.